Current role
Biotechnology · Healthcare
Board Member
2026-10-13–present
Jeffrey Farrow
Board Member
Lisata Therapeutics, Inc. (LSTA)Equibles does not estimate personal net worth.
About Jeffrey Farrow
Jeffrey Farrow is recorded as Board Member at Lisata Therapeutics, Inc. (LSTA) since October 13, 2026. Lisata Therapeutics, Inc. reported in an 8-K filed October 14, 2026 that Jeffrey Farrow was appointed Class III member of the Board, effective October 13, 2026. Lisata Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Lisata Therapeutics, Inc. includes David J. Mazzo (CEO and Board Member), David J. Mazzo, Ph.D. (CEO), Gregory Brown (Chairman) and 7 others.
“On October 13, 2026, upon the recommendation of the Nominating and Corporate Governance Committee, the Board of Directors (the "Board") of Lisata Therapeutics, Inc. (the "Company") approved an increase in the size of the Board from seven to eight members and appointed Jeffrey Farrow as a Class III member of the Board to fill the newly created seat effective immediately, with an initial term expiring at the Company's 2028 annual meeting of stockholders.”
Affiliation history
-
Current
2026-10-13–present
Company network
Leadership on record at Lisata Therapeutics, Inc.
- David J. Mazzo CEO, Board Member
- David J. Mazzo, Ph.D. CEO
- Gregory Brown Chairman
- Gregory Brown, M.D. Chairman
- Dr. Josh Lehrer COO
- Josh Lehrer COO
- Josh Lehrer, M.D., M.Phil., FACC COO
- Tariq Imam General Counsel
- James Nisco Chief Accounting Officer
- Anne Whitaker Board Member